Cargando…
Impact of the Swank and Wahls elimination dietary interventions on fatigue and quality of life in relapsing-remitting multiple sclerosis: The WAVES randomized parallel-arm clinical trial
OBJECTIVE: To compare the effect of the modified Paleolithic elimination (Wahls) and low-saturated fat (Swank) diets in relapsing-remitting MS (RRMS). METHODS: Individuals (n = 87) with RRMS were randomized to the Swank or Wahls diets in a parallel group clinical trial consisting of four timepoints:...
Autores principales: | Wahls, Terry L, Titcomb, Tyler J, Bisht, Babita, Eyck, Patrick Ten, Rubenstein, Linda M, Carr, Lucas J, Darling, Warren G, Hoth, Karin F, Kamholz, John, Snetselaar, Linda G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326636/ https://www.ncbi.nlm.nih.gov/pubmed/34377527 http://dx.doi.org/10.1177/20552173211035399 |
Ejemplares similares
-
Change in Micronutrient Intake among People with Relapsing-Remitting Multiple Sclerosis Adapting the Swank and Wahls Diets: An Analysis of Weighed Food Records
por: Titcomb, Tyler J., et al.
Publicado: (2021) -
Diet-induced changes in functional disability are mediated by fatigue in relapsing-remitting multiple sclerosis: A secondary analysis of the WAVES randomized parallel-arm trial
por: Crippes, Landon J, et al.
Publicado: (2023) -
Dietary approaches to treat MS-related fatigue: comparing the modified Paleolithic (Wahls Elimination) and low saturated fat (Swank) diets on perceived fatigue in persons with relapsing-remitting multiple sclerosis: study protocol for a randomized controlled trial
por: Wahls, Terry, et al.
Publicado: (2018) -
Nutrient Composition Comparison between the Low Saturated Fat Swank Diet for Multiple Sclerosis and Healthy U.S.-Style Eating Pattern
por: Chenard, Catherine A., et al.
Publicado: (2019) -
Association between improved metabolic risk factors and perceived fatigue during dietary intervention trial in relapsing-remitting multiple sclerosis: A secondary analysis of the WAVES trial
por: Villa, Aneli T., et al.
Publicado: (2023)